Patents by Inventor Naresh Mandava
Naresh Mandava has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220346943Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: ApplicationFiled: July 1, 2022Publication date: November 3, 2022Applicants: Alcon Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul MCLEAN, Robert E. ATKINSON
-
Patent number: 11406490Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: GrantFiled: May 10, 2017Date of Patent: August 9, 2022Assignees: Alcon Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Glenn Sussman, Paul McLean, Robert E. Atkinson
-
Publication number: 20220176141Abstract: Systems and methods for wireless neural stimulation are presented. A microstimulator comprising a highly magnetic permeable material is implanted in the tissue of a living body. A wearable external controller creates a time-varying magnetic field that extends to the microstimulator in the tissue. The microstimulator re-shapes and boosts the time-varying magnetic field in the area surrounding the microstimulator, causing neural stimulation in the area around the microstimulator. A physician programmer device is also presented that allows a physician to program the wearable external controller.Type: ApplicationFiled: April 1, 2020Publication date: June 9, 2022Inventors: Anthony V. Caparso, Richard J. Davis, Malik Kahook, Naresh Mandava
-
Patent number: 11291847Abstract: Described are systems and methods for preventing, diagnosing, and/or treating one or more medical conditions. The medical conditions can be ocular and/or neurological diseases, disorders, and/or conditions. The systems and methods can employ a microstimulator that is configured to be placed within an anatomical structure of a subject. The microstimulator can be capacitively linked to an external electronic device to provide neuromodulation to a biological target site proximal to the anatomical structure. The microstimulator can include a body and an electrically conductive insert arranged within the body to create a capacitively coupled link with the external electronic device. The electrically conductive insert can receive a power signal from an external electronic device and convert the power signal to deliver a therapy signal to the biological target site.Type: GrantFiled: December 22, 2017Date of Patent: April 5, 2022Assignee: The Regents of the University of Colorado, a body corporateInventors: Anthony V. Caparso, Malik Kahook, Naresh Mandava, Noah Lemire, Adam Farwick, Steve Wilder, Steve Risser
-
Publication number: 20200188670Abstract: Described are systems and methods for preventing, diagnosing, and/or treating one or more medical conditions. The medical conditions can be ocular and/or neurological diseases, disorders, and/or conditions. The systems and methods can employ a microstimulator that is configured to be placed within an anatomical structure of a subject. The microstimulator can be capacitively linked to an external electronic device to provide neuromodulation to a biological target site proximal to the anatomical structure. The microstimulator can include a body and an electrically conductive insert arranged within the body to create a capacitively coupled link with the external electronic device. The electrically conductive insert can receive a power signal from an external electronic device and convert the power signal to deliver a therapy signal to the biological target site.Type: ApplicationFiled: December 22, 2017Publication date: June 18, 2020Inventors: Anthony V. Caparso, Malik Kahook, Naresh Mandava, Noah Lemire, Adam Farwick, Steve Wilder, Steve Risser
-
Patent number: 10307150Abstract: The present disclosure relates to a structure used in an ophthalmic surgical procedure. The device may be used in pupil expansion or stabilization of the iris. The device is made out of an elastic or semielastic material in a shape that is conducive to easy insertion and removal as well as being optimized for atraumatic pupil expansion.Type: GrantFiled: June 11, 2015Date of Patent: June 4, 2019Assignee: The Regents of the University of Colorado, A Body CorporateInventors: Malik Y. Kahook, Naresh Mandava
-
Patent number: 10286105Abstract: A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimiz or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45.Type: GrantFiled: May 17, 2016Date of Patent: May 14, 2019Assignee: The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Robin Shandas, Bryan Rech
-
Patent number: 10286107Abstract: A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45.Type: GrantFiled: May 17, 2016Date of Patent: May 14, 2019Assignee: The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Robin Shandas, Bryan Rech, Michael D. Lowery, Daniel Urbaniak
-
Patent number: 10286106Abstract: A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45.Type: GrantFiled: May 17, 2016Date of Patent: May 14, 2019Assignee: The Regents of the University of ColoradoInventors: Malik Y. Kahook, Naresh Mandava, Robin Shandas, Bryan Rech
-
Patent number: 10272176Abstract: A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.Type: GrantFiled: May 17, 2016Date of Patent: April 30, 2019Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADOInventors: Malik Y. Kahook, Naresh Mandava, Robin Shandas, Bryan Rech
-
Publication number: 20180296726Abstract: A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.Type: ApplicationFiled: June 19, 2018Publication date: October 18, 2018Inventors: Malik Y. Kahook, Naresh Mandava, Robin Shandas, Bryan Rech, Michael D. Lowery, Daniel Urbaniak
-
Publication number: 20180154151Abstract: Described are systems and methods for preventing, diagnosing, and/or treating one or more medical conditions. The medical conditions can be ocular and/or neurological diseases, disorders, and/or conditions. The systems and methods can employ a microstimulator that is configured to be placed within an anatomical structure of a subject. The microstimulator can be capacitively linked to an external electronic device to provide neuromodulation to a biological target site proximal to the anatomical structure. The microstimulator can include a body and an electrically conductive insert arranged within the body to create a capacitively coupled link with the external electronic device. The electrically conductive insert can receive a power signal from an external electronic device and convert the power signal to deliver a therapy signal to the biological target site.Type: ApplicationFiled: January 19, 2018Publication date: June 7, 2018Inventors: Anthony V. Caparso, Malik Kahook, Naresh Mandava, Noah Lemire, Adam Farwick, Steve Wilder, Steve Risser
-
Publication number: 20180140841Abstract: Described are systems and methods for preventing, diagnosing, and/or treating one or more medical conditions. The medical conditions can be ocular and/or neurological diseases, disorders, and/or conditions. The systems and methods can employ a microstimulator that is configured to be placed within an anatomical structure of a subject. The microstimulator can be capacitively linked to an external electronic device to provide neuromodulation to a biological target site proximal to the anatomical structure. The microstimulator can include a body and an electrically conductive insert arranged within the body to create a capacitively coupled link with the external electronic device. The electrically conductive insert can receive a power signal from an external electronic device and convert the power signal to deliver a therapy signal to the biological target site.Type: ApplicationFiled: January 19, 2018Publication date: May 24, 2018Inventors: Anthony V. Caparso, Malik Kahook, Naresh Mandava, Noah Lemire, Adam Farwick, Steve Wilder, Steve Risser
-
Publication number: 20180133478Abstract: Described are systems and methods for preventing, diagnosing, and/or treating one or more medical conditions. The medical conditions can be ocular and/or neurological diseases, disorders, and/or conditions. The systems and methods can employ a microstimulator that is configured to be placed within an anatomical structure of a subject. The microstimulator can be capacitively linked to an external electronic device to provide neuromodulation to a biological target site proximal to the anatomical structure. The microstimulator can include a body and an electrically conductive insert arranged within the body to create a capacitively coupled link with the external electronic device. The electrically conductive insert can receive a power signal from an external electronic device and convert the power signal to deliver a therapy signal to the biological target site.Type: ApplicationFiled: December 22, 2017Publication date: May 17, 2018Inventors: Anthony V. Caparso, Malik Kahook, Naresh Mandava, Noah Lemire, Adam Farwick, Steve Wilder, Steve Risser
-
Patent number: 9877825Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.Type: GrantFiled: June 8, 2016Date of Patent: January 30, 2018Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson
-
Publication number: 20180014928Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: ApplicationFiled: May 10, 2017Publication date: January 18, 2018Applicants: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul McLEAN, Robert E. ATKINSON
-
Publication number: 20170265851Abstract: The present disclosure relates to a structure used in an ophthalmic surgical procedure. The device may be used in pupil expansion or stabilization of the iris. The device is made out of an elastic or semielastic material in a shape that is conducive to easy insertion and removal as well as being optimized for atraumatic pupil expansion.Type: ApplicationFiled: June 11, 2015Publication date: September 21, 2017Inventors: Malik Y. Kahook, Naresh Mandava
-
Patent number: 9681946Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: GrantFiled: February 26, 2016Date of Patent: June 20, 2017Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Glenn Sussman, Paul McLean, Robert E. Atkinson
-
Publication number: 20160278912Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.Type: ApplicationFiled: June 8, 2016Publication date: September 29, 2016Applicants: The Regents of the University of Colorado, a body corporate, ClarVista Medical, Inc.Inventors: Malik Y. KAHOOK, Naresh MANDAVA, Paul MCLEAN, Robert E. ATKINSON
-
Publication number: 20160256264Abstract: A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.Type: ApplicationFiled: May 17, 2016Publication date: September 8, 2016Inventors: Malik Y. Kahook, Naresh Mandava, Robin Shandas, Bryan Rech